Patients with adrenal incidentaloma (AI) and subclinical hypercortisolism (SH) show a high prevalence of cardiovascular risk factors and an increased prevalence and incidence of cardiovascular events. Furthermore, some recent data suggest that in these patients, the cardiovascular mortality is also increased. Unfortunately, to date, the diagnosis of SH is still a matter of debate, and, therefore, it is still not possible to address the treatment of choice (i.e. surgical or conservative approach) in many AI patients. Overall, the available data show that in AI patients with established SH the surgical removal of the adrenal mass causing SH can lead to the improvement of hypertension and diabetes, but in many patients with possible SH the effect of surgery is still largely unknown. Finally, no data are available on the effect of the recovery from SH on the cardiovascular events. Therefore, randomized studies are needed to investigate the possibility of predicting the usefulness of surgery by using the available indexes of cortisol secretion in the individual AI patient. Finally, the development of safe and well-tolerated drugs aimed to control cortisol secretion will be among the goals of the future research.

Cardiovascular mortality in patients with subclinical Cushing = Mortalité cardiovasculaire dans les syndromes de Cushing infracliniques / V. Morelli, M. Arosio, I. Chiodini. - In: ANNALES D'ENDOCRINOLOGIE. - ISSN 0003-4266. - 79:3(2018 Jun), pp. 149-152. [10.1016/j.ando.2018.03.005]

Cardiovascular mortality in patients with subclinical Cushing = Mortalité cardiovasculaire dans les syndromes de Cushing infracliniques

V. Morelli;M. Arosio;I. Chiodini
2018-06

Abstract

Patients with adrenal incidentaloma (AI) and subclinical hypercortisolism (SH) show a high prevalence of cardiovascular risk factors and an increased prevalence and incidence of cardiovascular events. Furthermore, some recent data suggest that in these patients, the cardiovascular mortality is also increased. Unfortunately, to date, the diagnosis of SH is still a matter of debate, and, therefore, it is still not possible to address the treatment of choice (i.e. surgical or conservative approach) in many AI patients. Overall, the available data show that in AI patients with established SH the surgical removal of the adrenal mass causing SH can lead to the improvement of hypertension and diabetes, but in many patients with possible SH the effect of surgery is still largely unknown. Finally, no data are available on the effect of the recovery from SH on the cardiovascular events. Therefore, randomized studies are needed to investigate the possibility of predicting the usefulness of surgery by using the available indexes of cortisol secretion in the individual AI patient. Finally, the development of safe and well-tolerated drugs aimed to control cortisol secretion will be among the goals of the future research.
Adrenal incidentaloma; Cardiovascular mortality; Subclinical hypercortisolism; Endocrinology, Diabetes and Metabolism; Endocrinology
Settore MED/13 - Endocrinologia
30-mar-2018
Article (author)
File in questo prodotto:
File Dimensione Formato  
Cardiovascular mortality in patients with subclinical Cushing - Ann Endocrinol (Paris) 2018.pdf

accesso riservato

Tipologia: Pre-print (manoscritto inviato all'editore)
Dimensione 210.53 kB
Formato Adobe PDF
210.53 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
1-s2.0-S0003426618300301-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 169.23 kB
Formato Adobe PDF
169.23 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/585064
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 18
social impact